Tokyo Tape
Sign in
← SymBio Pharmaceuticals

Annual report

4582.TEDINET S100VGDJ
Period2024-01-01 → 2024-12-31
Filed2025-03-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 121
MetricValuePeriodScopeSource row
Revenue¥2.5bn2024-01-01 → 2024-12-31Cons.Net sales
Revenue¥5.6bn2023-01-01 → 2023-12-31Cons.Net sales
Revenue¥10.0bn2022-01-01 → 2022-12-31dCons.Net sales (5-year summary)
Operating income−¥3.9bn2024-01-01 → 2024-12-31Cons.Operating income
Operating income−¥812m2023-01-01 → 2023-12-31Cons.Operating income
Ordinary income−¥3.7bn2024-01-01 → 2024-12-31Cons.Ordinary income
Ordinary income−¥736m2023-01-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31dCons.Ordinary income loss (5-year summary)
Profit before tax−¥3.8bn2024-01-01 → 2024-12-31Cons.Income before income taxes
Profit before tax−¥1.2bn2023-01-01 → 2023-12-31Cons.Income before income taxes
Net income (owners)−¥3.8bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥2.0bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.2bn2022-01-01 → 2022-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income−¥3.8bn2024-01-01 → 2024-12-31Cons.Profit loss
Net income−¥2.0bn2023-01-01 → 2023-12-31Cons.Profit loss
Total assets¥5.0bnat 2024-12-31Cons.Assets
Total assets¥8.2bnat 2023-12-31Cons.Assets
Total assets¥10.4bnat 2022-12-31dCons.Total assets (5-year summary)
Total liabilities¥771mat 2024-12-31Cons.Liabilities
Total liabilities¥960mat 2023-12-31Cons.Liabilities
Net assets / equity¥4.2bnat 2024-12-31Cons.Net assets
Net assets / equity¥7.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥8.5bnat 2022-12-31dCons.Net assets
Cash and deposits¥4.0bnat 2024-12-31Cons.Cash and deposits
Cash and deposits¥6.5bnat 2023-12-31Cons.Cash and deposits
Cash & equivalents¥4.0bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.5bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.3bnat 2022-12-31dCons.Cash and cash equivalents
Operating cash flow−¥3.4bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥195m2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.6bn2022-01-01 → 2022-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥4m2024-01-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥377m2023-01-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥47m2022-01-01 → 2022-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥708m2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥680m2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥628m2022-01-01 → 2022-12-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥-852024-01-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-49.192023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.22022-01-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥29.772022-01-01 → 2022-12-31dCons.Diluted earnings per share (5-year summary)
Net assets per share¥84.66at 2024-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥164.32at 2023-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥204.83at 2022-12-31dCons.Net assets per share (5-year summary)
Equity ratio78.1%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio84.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.6%at 2022-12-31dCons.Equity to asset ratio (5-year summary)
ROE14.6%2022-01-01 → 2022-12-31dCons.Rate of return on equity (5-year summary)
Employees108at 2024-12-31Cons.Number of employees
Employees109at 2023-12-31Cons.Number of employees
Employees122at 2022-12-31dCons.Number of employees
Revenue¥2.5bn2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥5.6bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥10.0bn2022-01-01 → 2022-12-31dStandaloneNet sales (5-year summary)
Revenue¥8.3bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥3.0bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Operating income−¥4.0bn2024-01-01 → 2024-12-31StandaloneOperating income
Operating income−¥852m2023-01-01 → 2023-12-31StandaloneOperating income
Ordinary income−¥3.8bn2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income−¥774m2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥1.0bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥4.6bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥3.9bn2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Profit before tax−¥1.2bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Net income−¥3.9bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income−¥2.0bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥1.2bn2022-01-01 → 2022-12-31dStandaloneNet income loss (5-year summary)
Net income¥2.0bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Total assets¥4.7bnat 2024-12-31StandaloneAssets
Total assets¥8.2bnat 2023-12-31StandaloneAssets
Total assets¥10.4bnat 2022-12-31dStandaloneTotal assets (5-year summary)
Total assets¥8.5bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥6.3bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥639mat 2024-12-31StandaloneLiabilities
Total liabilities¥980mat 2023-12-31StandaloneLiabilities
Net assets / equity¥4.1bnat 2024-12-31StandaloneNet assets
Net assets / equity¥7.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥8.5bnat 2022-12-31dStandaloneNet assets
Net assets / equity¥6.7bnat 2021-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥4.7bnat 2020-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥3.7bnat 2024-12-31StandaloneCash and deposits
Cash and deposits¥6.3bnat 2023-12-31StandaloneCash and deposits
Cash & equivalents¥3.9bnat 2021-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.8bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥140m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥71m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥160m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥72m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.2bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-872024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-49.792023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥30.372022-01-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.042021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-124.132020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥29.952022-01-01 → 2022-12-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥52.322021-01-01 → 2021-12-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥82.12at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥164.02at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥204.95at 2022-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥162.26at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥105.76at 2020-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio79.7%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio84.6%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.8%at 2022-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio73.7%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio64.3%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE16.6%2022-01-01 → 2022-12-31dStandaloneRate of return on equity (5-year summary)
ROE39.6%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued45,928,856at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued42,278,081at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued39,603,606at 2022-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued38,457,206at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued38,202,956at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees101at 2024-12-31StandaloneNumber of employees
Employees103at 2023-12-31StandaloneNumber of employees
Employees118at 2022-12-31dStandaloneNumber of employees
Employees141at 2021-12-31dStandaloneNumber of employees
Employees127at 2020-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Research And Development Manufacturing And Sales Of Pharmaceuticals Etc And Related Businessreportable segmentemployeesat 2024-12-31108 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,250
ItemContextValueUnit
Effect of exchange rate change on cash and cash equivalentsCurrentYearDuration158574000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration234452000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration-2553426000JPY
Cash and cash equivalentsPrior2YearInstant6282554000JPY
Cash and cash equivalentsPrior1YearInstant6517007000JPY
Cash and cash equivalentsPrior1YearInstant6517007000JPY
Cash and cash equivalentsCurrentYearInstant3963580000JPY
Number of consolidated subsidiariesCurrentYearInstant1
Write downs of inventoriesPrior1YearDuration91439000JPY
Write downs of inventoriesCurrentYearDuration－JPY
Promotion expenses sgaPrior1YearDuration937821000JPY
Promotion expenses sgaCurrentYearDuration692838000JPY
Directors compensations sgaPrior1YearDuration130414000JPY
Directors compensations sgaCurrentYearDuration151750000JPY
Payroll and allowances sgaPrior1YearDuration446506000JPY
Payroll and allowances sgaCurrentYearDuration466873000JPY
Retirement benefit expenses sgaPrior1YearDuration796000JPY
Retirement benefit expenses sgaCurrentYearDuration1346000JPY
Research and development expenses sgaPrior1YearDuration2638234000JPY
Research and development expenses sgaCurrentYearDuration3379471000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodPrior1YearDuration2638234000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodCurrentYearDuration3379471000JPY
Cash and depositsPrior1YearInstant_NonConsolidatedMember6276521000JPY
Cash and depositsCurrentYearInstant_NonConsolidatedMember3717087000JPY
Accounts receivable tradePrior1YearInstant_NonConsolidatedMember913094000JPY
Accounts receivable tradeCurrentYearInstant_NonConsolidatedMember423153000JPY
Merchandise and finished goodsPrior1YearInstant_NonConsolidatedMember231650000JPY
Merchandise and finished goodsCurrentYearInstant_NonConsolidatedMember115188000JPY
Semi finished goodsPrior1YearInstant_NonConsolidatedMember－JPY
Semi finished goodsCurrentYearInstant_NonConsolidatedMember61798000JPY
SuppliesPrior1YearInstant_NonConsolidatedMember380000JPY
SuppliesCurrentYearInstant_NonConsolidatedMember61933000JPY
Advance payments tradePrior1YearInstant_NonConsolidatedMember271516000JPY
Advance payments tradeCurrentYearInstant_NonConsolidatedMember115126000JPY
Prepaid expensesPrior1YearInstant_NonConsolidatedMember366524000JPY
Prepaid expensesCurrentYearInstant_NonConsolidatedMember110947000JPY
Consumption taxes receivablePrior1YearInstant_NonConsolidatedMember－JPY
Consumption taxes receivableCurrentYearInstant_NonConsolidatedMember33183000JPY
Other caPrior1YearInstant_NonConsolidatedMember29607000JPY
Other caCurrentYearInstant_NonConsolidatedMember36849000JPY
Current assetsPrior1YearInstant_NonConsolidatedMember8089294000JPY
Current assetsCurrentYearInstant_NonConsolidatedMember4675267000JPY
Stocks of subsidiaries and affiliatesPrior1YearInstant_NonConsolidatedMember0JPY
Stocks of subsidiaries and affiliatesCurrentYearInstant_NonConsolidatedMember0JPY
Lease and guarantee depositsPrior1YearInstant_NonConsolidatedMember87716000JPY
Lease and guarantee depositsCurrentYearInstant_NonConsolidatedMember44102000JPY
Investments and other assetsPrior1YearInstant_NonConsolidatedMember87716000JPY
Investments and other assetsCurrentYearInstant_NonConsolidatedMember44102000JPY
Noncurrent assetsPrior1YearInstant_NonConsolidatedMember87716000JPY
Noncurrent assetsCurrentYearInstant_NonConsolidatedMember44102000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2023-12-31pass
balance sheet identityconsolidated 2024-12-31pass rounding
balance sheet identitynon_consolidated 2023-12-31pass
balance sheet identitynon_consolidated 2024-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass